Insufficient funding and personnel for research and development, and employee attrition
First written in FY2016. 31 of 33 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026RestatedAnnual report
「・Ongoing development and recruitment of research and development personnel ・Use of outsourcing in parallel ・Securing a research and development budget above a specified amount ・Establishment of an independent group (the Technology Development Group) ・Integrating manufacturing, sales and administration to deliver solutions」
Countermeasures against insufficient personnel and funding required for research and development and employee attrition were continued. - FY2026-H1RestatedAnnual report
「During the interim accounting period, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient personnel and funding required for research and development and employee attrition. - FY2025RestatedAnnual report
「・Ongoing development and recruitment of research and development personnel ・Use of outsourcing in parallel ・Securing a research and development budget above a specified amount ・Establishment of an independent group (the Technology Development Group) ・Integrating manufacturing, sales and administration to deliver solutions」
Countermeasures including development and recruitment, outsourcing, securing a budget and establishing a Technology Development Group were continued in response to insufficient personnel and funding required for research and development and employee attrition. - FY2024RestatedAnnual report
「・Ongoing development and recruitment of research and development personnel ・Use of outsourcing in parallel ・Securing a research and development budget above a specified amount ・Establishment of an independent group (the Technology Development Group) ・Integrating manufacturing, sales and administration to deliver solutions」
Countermeasures including development and recruitment, outsourcing, securing a budget and establishing a Technology Development Group were continued in response to insufficient personnel and funding required for research and development and employee attrition. - FY2024-Q3RestatedAnnual report
「During the cumulative third quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2024-Q2RestatedAnnual report
「During the cumulative second quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2024-Q1RestatedAnnual report
「During the cumulative first quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2023-Q3RestatedAnnual report
「During the cumulative third quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2023-Q1RestatedAnnual report
「During the cumulative first quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2022RestatedAnnual report
「・Ongoing development and recruitment of research and development personnel ・Use of outsourcing in parallel ・Securing a research and development budget above a specified amount ・Establishment of an independent group (the Technology Development Group) ・Integrating manufacturing, sales and administration to deliver solutions」
Countermeasures including development and recruitment, outsourcing, securing a budget and establishing a Technology Development Group were continued in response to the risk of a weakened research and development structure. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2022-Q1RestatedAnnual report
「During the cumulative first quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2021RestatedAnnual report
「・Ongoing development and recruitment of research and development personnel ・Use of outsourcing in parallel ・Securing a research and development budget above a specified amount ・Establishment of an independent group (the Technology Development Group)」
Countermeasures including development and recruitment, outsourcing, securing a budget and establishing a Technology Development Group were continued in response to the risk of a weakened research and development structure. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2021-Q1RestatedAnnual report
「During the cumulative first quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2020ReframedAnnual report
「・Ongoing development and recruitment of research and development personnel ・Use of outsourcing in parallel ・Securing a research and development budget above a specified amount ・Establishment of an independent group (the Technology Development Group) ・Integrating manufacturing, sales and administration to deliver solutions」
The existing risks of insufficient funding and personnel for research and development and employee attrition were reorganized as a weakening of the research and development structure, with countermeasures including development and recruitment, outsourcing, securing a budget and establishing a Technology Development Group explicitly stated. - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2020-Q2RestatedAnnual report
「During the cumulative second quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2020-Q1RestatedAnnual report
「During the cumulative first quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2019RestatedAnnual report
「As a water solutions company that applies its proprietary technologies and know-how to address a wide range of water- and fluid-related challenges, the Company needs to continue research and development in order to respond to constantly changing market conditions and customer needs. If the Company is unable to secure the funding and personnel required for its research and development structure, or if its personnel leave for outside organizations, its business development and operating results could be affected.」
The risks of insufficient funding and personnel required for research and development and employee attrition were continued in the disclosure. - FY2019-Q3RestatedAnnual report
「During the cumulative third quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2019-Q2RestatedAnnual report
「During the cumulative second quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2019-Q1RestatedAnnual report
「During the cumulative first quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2018RestatedAnnual report
「If the Company is unable to secure the funding and personnel required for its research and development structure, or if its personnel leave for outside organizations, its business development and operating results could be affected.」
The risks of insufficient funding and personnel required for research and development and employee attrition were continued in the disclosure. - FY2018-Q3RestatedAnnual report
「During the cumulative third quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2018-Q1RestatedAnnual report
「During the cumulative first quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2017RestatedAnnual report
「If the Company is unable to secure the funding and personnel required for its research and development structure, or if its personnel leave for outside organizations, its business development and operating results could be affected.」
The risks of insufficient funding and personnel required for research and development and employee attrition were continued in the disclosure. - FY2017-Q3RestatedAnnual report
「During the cumulative third quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2017-Q2RestatedAnnual report
「During the cumulative second quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2017-Q1RestatedAnnual report
「During the cumulative first quarter, there were no new business or other risks, nor any material changes to the business and other risks described in the securities report for the previous fiscal year.」
It was explicitly stated that there were no material changes from the prior year's disclosure regarding the risks of insufficient funding and personnel required for research and development and employee attrition. - FY2016First statedAnnual report
「If the Company is unable to secure the funding and personnel required for its research and development structure, or if its personnel leave for outside organizations, its business development and operating results could be affected.」
The risk of being unable to secure the funding and personnel required to continue research and development, as well as employee attrition, was disclosed.